Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells

Molecular Pharmacology

Volumn 74, Issue 5, 2008, Pages 1223-1233

  Yin, Xing ^a   Li, Bo ^b   Chen, Hungdar ^a   Catt, Kevin J ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANDROSTADIENES; ANGIOTENSIN II; BASE SEQUENCE; CALCIUM; CELL LINE; CHOLESTEROL; CHROMONES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FILIPIN; HUMANS; LIVER; MORPHOLINES; NYSTATIN; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 54349129564     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048504     Document Type: Article

References (40)

1. Adi S, Wu NY, and Rosenthal SM (2001) Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. Endocrinology 142:498-501.
2. Anderson RG (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225.
3. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, and Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15:5256-5267.
4. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657.
5. Cantrell DA (2001) Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114:1439-1445.
6. Carver RS, Stevenson MC, Scheving LA, and Russell WE (2002) Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology 123:2017-2027.
7. 2+ influx in afferent arterioles. Hypertension 40:700-706.
8. Clapham DE (1995) Calcium signaling. Cell 80:259-268.
9. Cohen AW, Hnasko R, Schubert W, and Lisanti MP (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84:1341-1379.
10. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
11. Eguchi S and Inagami T (2000) Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20.
12. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, et al. (1998) Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
13. Ethier MF and Madison JM (2002) LY294002, but not wortmannin, increases intracellular calcium and inhibits calcium transients in bovine and human airway smooth muscle cells. Cell Calcium 32:31-38.
14. Fleming JM, Desury G, Polanco TA, and Cohick WS (2006) Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells. Endocrinology 147:6027-6035.
15. 1 receptor phosphorylation and desensitization in a hepatic cell line. Roles of protein kinase C and phosphoinositide 3-kinase. Mol Pharmacol 59:576-585.
16. Ghosh A and Greenberg ME (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239-247.
17. 2+ signaling, ERK 1/2 activation, mitogenesis and vasodilator production. J Endocrinol 182:485-499.
18. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, and Alexander RW (1986) Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 261:5901-5906.
19. Haendeler J and Berk BC (2000) Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regul Pept 95:1-7.
20. Haendeler J, Yin G, Hojo Y, Saito Y, Melaragno M, Yan C, Sharma VK, Heller M, Aebersold R, and Berk BC (2003) GIT1 mediates Src-dependent activation of phospholipase Cγ by angiotensin II and epidermal growth factor. J Biol Chem 278:49936-49944.
21. Hunyady L, Baukal AJ, Gaborik Z, Olivares-Reyes JA, Bor M, Szaszak M, Lodge R, Catt KJ, and Balla T (2002) Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. J Cell Biol 157:1211-1222.
22. Ishizaka N, Griendling KK, Lasségue B, and Alexander RW (1998) Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-466.
23. Janas E, Priest R, Wilde JI, White JH, and Malhotra R (2005) Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin Exp Immunol 139:439-446.
24. Kiyatkin A, Aksamitiene E, Markevich NI, Borisov NM, Hoek JB, and Kholodenko BN (2006) Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops. J Biol Chem 281:19925-19938.
25. Kumar R, Singh VP, and Baker KM (2007) The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 18:208-214.
26. 2+ store depletion in rat liver epithelial cells. Am J Physiol 276:C221-C230.
27. Mifune M, Ohtsu H, Suzuki H, Nakashima H, Brailoiu E, Dun NJ, Frank GD, Inagami T, Higashiyama S, Thomas WG, et al. (2005) G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 280:26592-26599.
28. Mineo C, James GL, Smart EJ, and Anderson RG (1996) Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:11930-11935.
29. i-coupled Src kinase signaling pathway. J Cell Biol 150:1057-1070.
30. 1 and epidermal growth factor receptors. Mol Pharmacol 68:356-364.
31. Paugh BS, Paugh SW, Bryan L, Kapitonov D, Wilczynska KM, Gopalan SM, Rokita H, Milstien S, Spiegel S, and Kordula T (2008) EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKC{delta}, and sphingosine kinase 1 in glioblastoma cells. FASEB J 22:455-465.
32. Shah BH and Catt KJ (2002) Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cδ, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. Mol Pharmacol 61:343-351.
33. Shah BH and Catt KJ (2003) A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24:239-244.
34. Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, and Catt KJ (2004) Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Mol Endocrinol 18:2035-2048.
35. Shaul PW and Anderson RG (1998) Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275:L843-L851.
36. Tolloczko B, Turkewitsch P, Al-Chalabi M, and Martin JG (2004) LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition. J Pharmacol Exp Ther 311:787-793.
37. Ushio-Fukai M and Alexander RW (2006) Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 48:797-803.
38. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW (2001). Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276:48269-48275.
39. Yin X, Polidano E, Faverdin C, and Marche P (2005) Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. J Hypertens 23:337-350.
40. 2+ entry in a human salivary cell line. J Biol Chem 277:48165-48171.